Untreated Adult Acute Myeloid Leukemia Active Not Recruiting Phase 2 Trials for Bortezomib (DB00188)

IndicationStatusPhase
DBCOND0028532 (Untreated Adult Acute Myeloid Leukemia)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01420926Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid LeukemiaTreatment